Safety of Compounded Medications.

IF 1.3 Q3 MEDICINE, GENERAL & INTERNAL Cureus Pub Date : 2025-02-05 eCollection Date: 2025-02-01 DOI:10.7759/cureus.78541
Rohini Garg, Harmit Singh
{"title":"Safety of Compounded Medications.","authors":"Rohini Garg, Harmit Singh","doi":"10.7759/cureus.78541","DOIUrl":null,"url":null,"abstract":"<p><p>Compounded medications are medications that are prepared by compounding pharmacies to meet individual patients' needs that cannot be met by FDA-approved brand name or generic medications. This may be the case when a patient needs a different dose or route of administration or if a patient is allergic to a certain ingredient in an FDA-approved medication. While compounded medications help to fill a necessary gap, they can have significant safety issues. Due to lesser regulatory oversight, patient safety may be compromised due to contamination or inaccurate potency of compounded medications. Compounded medications should be prescribed only when an FDA-approved medication cannot be used, and the benefits outweigh the risks. Enforcement of adequate oversight by regulatory agencies and maintenance of strict safety precautions at the compounding facilities are needed to ensure patient safety.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 2","pages":"e78541"},"PeriodicalIF":1.3000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11796295/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cureus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7759/cureus.78541","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Compounded medications are medications that are prepared by compounding pharmacies to meet individual patients' needs that cannot be met by FDA-approved brand name or generic medications. This may be the case when a patient needs a different dose or route of administration or if a patient is allergic to a certain ingredient in an FDA-approved medication. While compounded medications help to fill a necessary gap, they can have significant safety issues. Due to lesser regulatory oversight, patient safety may be compromised due to contamination or inaccurate potency of compounded medications. Compounded medications should be prescribed only when an FDA-approved medication cannot be used, and the benefits outweigh the risks. Enforcement of adequate oversight by regulatory agencies and maintenance of strict safety precautions at the compounding facilities are needed to ensure patient safety.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
复方药物的安全性。
复合药物是由复合药房制备的药物,以满足fda批准的品牌药物或非专利药物无法满足的个体患者的需求。当患者需要不同的剂量或给药途径时,或者患者对fda批准的药物中的某种成分过敏时,可能会出现这种情况。虽然复合药物有助于填补必要的空白,但它们可能存在严重的安全问题。由于较少的监管监督,患者的安全可能会因污染或复方药物效力不准确而受到损害。只有当fda批准的药物不能使用时,才应该开复方药物,而且利大于弊。需要监管机构实施充分的监督,并在配制设施中保持严格的安全预防措施,以确保患者安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
What Makes Medical Education Meaningful: A Qualitative Evaluation of Student and Educator Perspectives on UK Clinical Education. Hereditary Bilateral Retinoblastoma Detected on Screening in a Two-Month-Old Infant With a Strong Family History. Apocrine Hidrocystoma of Foreskin: A Rare Benign Cystic Lesion. Acute Sulfite-Induced Hypersensitivity Reaction Following Balsamic Vinegar Consumption: A Case Report. Daptomycin-Induced Eosinophilic Pneumonia in a Patient With Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Undergoing Hemodialysis: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1